Allosteric Modulation of Adenosine A2A Receptors as a New Therapeutic Avenue.

ABSTRACT: The therapeutic potential of targeting adenosine A2A receptors (A2ARs) is immense due to their broad expression in the body and central nervous system. The role of A2ARs in cardiovascular function, inflammation, sleep/wake behaviors, cognition, and other primary nervous system functions has been extensively studied. Numerous A2AR agonist and antagonist molecules are reported, many of which are currently in clinical trials or have already been approved for treatment. Allosteric modulators can selectively elicit a physiologic response only where and when the orthosteric ligand is released, which reduces the risk of an adverse effect resulting from A2AR activation. Thus, these allosteric modulators have a potential therapeutic advantage over classical agonist and antagonist molecules. This re

SUBMITTER: Korkutata M 

PROVIDER: S-EPMC8880556 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature